Amarin Corp Plcuk (AMRN) Total Current Liabilities (2010 - 2026)

Amarin Corp Plcuk (AMRN) reported Total Current Liabilities of $179.6 million for Q1 2026, up 10.61% year-over-year from $162.4 million in Q1 2025, and down 7.62% quarter-over-quarter from $194.5 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Total Current Liabilities (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 17 years of Total Current Liabilities data on file, last reported at $179.6 million in Q1 2026.

  • Total Current Liabilities for Q1 2026 came in at $179.6 million, up 10.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $179.6 million (up 10.61% YoY), and the FY2025 annual result was $194.5 million, up 8.06% from the prior year.
  • Total Current Liabilities eased to $179.6 million in Q1 2026 per AMRN's latest filing, from $194.5 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $361.6 million in Q2 2022 and troughed at $162.4 million in Q1 2025.
  • A 5-year average of $234.8 million and a median of $230.5 million in 2024 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2024 and 2026: Total Current Liabilities sank 30.6% in 2024, then gained 10.61% in 2026.
  • A 5-year view of Total Current Liabilities shows it stood at $259.5 million in 2022, then slipped by 0.08% to $259.3 million in 2023, then slumped by 30.6% to $179.9 million in 2024, then increased by 8.06% to $194.5 million in 2025, then decreased by 7.62% to $179.6 million in 2026.
  • Business Quant data shows AMRN's Total Current Liabilities at $179.6 million in Q1 2026, $194.5 million in Q4 2025, and $182.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -30.24 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 36.63 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 57.72 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 42.10 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 26.95 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 24.96 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 9.48 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 34.35 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 19.16 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn 179.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 179.64 Mn
Dec 31, 2025 194.46 Mn
Sep 30, 2025 182.23 Mn
Jun 30, 2025 185.95 Mn
Mar 31, 2025 162.41 Mn
Dec 31, 2024 179.95 Mn
Sep 30, 2024 201.55 Mn
Jun 30, 2024 230.54 Mn
Mar 31, 2024 224.38 Mn
Dec 31, 2023 259.28 Mn
Sep 30, 2023 266.69 Mn
Jun 30, 2023 270.93 Mn
Mar 31, 2023 244.24 Mn
Dec 31, 2022 259.48 Mn
Sep 30, 2022 287.36 Mn
Jun 30, 2022 361.57 Mn
Mar 31, 2022 300.57 Mn
Dec 31, 2021 370.68 Mn
Sep 30, 2021 364.75 Mn
Jun 30, 2021 370.44 Mn